Fulgent Genetics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for FLGT, updated each market day.
FLGT AI Sentiment
AI predicts Fulgent Genetics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Fulgent Genetics, Inc. Common Stock
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Sector
Exchange
Market Cap
$601,209,152
Cap Tier
Employees
1,315
Headquarters
EL MONTE, CA
Listed Since
Sept. 29, 2016
Website
FLGT Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FLGT Volatility
Fulgent Genetics, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
